FM Global, Hearst Ventures and QBE Ventures are set to exit the insurance analysis software provider in an acquisition by Bold Penguin.

University of Wyoming-backed Momentus is set to merge with SPAC Stable Road Acquisition in a deal that values the space infrastructure company at $1.2bn.

McKesson Ventures was among the existing investors that provided $25m through a private placement that supported the deal between Augmedix and Malo Holdings.

Ping An's lending and wealth management spinoff, valued above $39bn two years ago, has selected the New York Stock Exchange for its flotation.

The Novo-backed CAH therapy developer has set the range for an offering set to net it between $60m and $80m in proceeds.

MIT's cancer therapy developer has set terms for an offering that will raise more than $185m if it floats at the top of its range.

10x Genomics has bought Harvard's genetic sequencing system provider and also revealed it closed its purchase of Stockholm University spinout CartaNA.

The GV-backed health insurance provider has agreed to merge with a special purpose acquisition company in a deal that will value it at $3.7bn.

GV is in line for an exit as the cancer therapy developer set terms for an offering that will raise more than $185m if it floats at the top of its range.

Eli Lilly will exit the genetic sequencing system provider in a cash-and-share acquisition by 10x Genomics that followed $50m in funding.